Reoperation for recurrent glioblastoma multiforme

Keyphrases

• Tumor 100%
• Reoperation 100%
• Recurrent Glioblastoma multiforme 100%
• Extent of Resection 100%
• Recurrent Glioblastoma 100%
• Clinical Trials 50%
• Tumor Progression 50%
• Surgeons 50%
• Treatment Effect 50%
• Brain Regions 50%
• Patient Well-being 50%
• Surgical Resection 50%
• Functional Imaging 50%
• Karnofsky Performance Status 50%
• Improved Survival 50%
• Chemotherapy-induced 50%
• Perfusion 50%
• Temozolomide 50%
• New Treatment Options 50%
• Chemoradiation 50%
• Radiation Effects 50%
• Glioblastoma multiforme 50%
• Glioblastoma Progression 50%
• Newly Diagnosed Glioblastoma 50%
• 5-Aminolevulinic Acid (5-ALA) 50%
• Intraoperative Magnetic Resonance Imaging (iMRI) 50%
• Microsurgical Resection 50%
• Eloquent Cortex 50%
• Surgical Adjunct 50%
• Neuroimaging Modalities 50%
• Postoperative Neurological Deficit 50%
• Treatment Resistance 50%
• Repeat Resection 50%
• Functional Testing 50%
• Fluorescence-guided 50%
• Residual Tumor Volume 50%
• Postoperative Residual 50%
• Eloquent Brain Areas 50%
• Tumor Banking 50%

Neuroscience

• Functional Imaging 100%
• Magnetic Resonance Imaging 100%
• Glioblastoma Multiforme 100%
• Aminolevulinic Acid 100%
• Temozolomide 100%
• Brain Region 100%
• Quality of Life 100%

Medicine and Dentistry

• Glioblastoma 100%
• Reoperation 100%
• Neoplasm 66%
• Quality of Life 16%
• Clinical Trial 16%
• Tumor Progression 16%
• Surgeon 16%
• Functional Imaging 16%
• Microsurgery 16%
• Karnofsky Performance Status 16%
• Brain Region 16%
• Treatment Effect 16%
• Retrospective Study 16%
• Chemoradiotherapy 16%
• Temozolomide 16%
• Aminolevulinic Acid 16%
• Intraoperative MRI 16%